Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
80 Results Found
Key Highlights of the Final One Big Beautiful Bill Act
The Senate July 1, and the House July 2, passed a budget reconciliation bill, the One Big Beautiful Bill Act (OBBBA), H.R. 1, a sweeping package that enacts many of President Trump’s legislative priorities on taxes, border security, energy and deficit reduction. The bill includes significant policy changes to Medicaid and the Health Insurance Marketplaces.
Senator Scott’s Amendment Withdrawn from Senate Vote
Sen. Rick Scott, R-Fla., has withdrawn his amendment to the Senate’s budget reconciliation bill. This withdrawal comes after a vigorous advocacy campaign by the AHA, with the great assistance of our members, to urge senators to vote no on the amendment.
Scott Amendment Could Drastically Impact Medicaid Expansion States
Senator Rick Scott, R-Fla., is expected to introduce an amendment to the Senate budget reconciliation bill during the vote-a-rama in the coming hours. The amendment would dramatically impact expansion states.
Estimated Impact of FMAP Reduction
The table below summarizes the 10-year impact on federal Medicaid hospital spending if the Federal Medical Assistance Percentage (FMAP) were reduced to the traditional level for Medicaid expansion enrollees due to program churn.
AHA Urges Senate to Amend Budget Reconciliation Bill Before Final Passage
The magnitude of nearly a trillion-dollar reduction to the Medicaid program cannot be characterized solely as waste, fraud and abuse. The real-life consequences of these reductions will result in irreparable harm to access to care for all Americans and undermine the ability of hospitals and health systems to care for our most vulnerable patients.
Regulatory Relief to Promote Domestic Production of Critical Medicines
Directs the Commissioner of the Food and Drug Administration to review and eliminate any duplicative or unnecessary requirements in regulations and guidance pertaining to the development of domestic pharmaceutical manufacturing within 180 days.
AHA Statement to House Energy & Commerce Subcommittee on Health Hearing for June 11, 2025
AHA statement for the record to the Committee on Energy and Commerce Health Subcommittee hearing “Made in America: Strengthening Domestic Manufacturing and the Health Care Supply Chain.”
AHA Comments on the Proposed Change to Section 301 Tariffs for Goods Made in China – 90183100
June 28, 2024 The Honorable Katherine TaiU.S. Trade Representative600 17th Street NWWashington, DC 20508